Variable | Value |
---|---|
Age (years), mean (range) | 50.02 (18–77) |
Course of disease (months), mean (range) | 17.82 (0.33–108) |
Schooling years (years), (range) | 9.37 (4–18) |
Completion time (min), mean (range) | 5.64 (1.37–15) |
Patients enrolled, n (%) | |
Outpatients | 76 (75.25) |
Inpatients | 25 (24.75) |
Sex, n (%) | |
Male | 67 (66.34) |
Female | 34 (33.66) |
Autoimmune bullous disease, n (%) | |
Pemphigus vulgaris | 57 (56.44) |
Bullous pemphigoid | 25 (24.75) |
Pemphigus foliaceus | 11 (10.89) |
Dermatitis herpetiformis | 3 (2.97) |
Linear IgA bullous dermatoses | 2 (1.98) |
Eidermolysis bullosa acquisita | 1 (0.99) |
Paraneoplastic pemphigus | 1 (0.99) |
Pemphigoid gestationis | 1 (0.99) |
Clinical stages, n (%) | |
baseline | 5 (4.95) |
complete remission during tapering | 23 (22.77) |
complete remission on minimal therapy | 29 (28.71) |
complete remission off therapy | 2 (1.98) |
control of disease activity | 30 (29.70) |
partial remission on minimal therapy | 2 (1.98) |
time to control of disease activity | 8 (7.92) |
relapse/flare | 2 (1.98) |